Endometrial stromal sarcoma presenting as postpartum haemorrhage: Report of a case with a sole t(10;17)(q22;p13) translocation

Gynecologic Oncology

Volumn 91, Issue 1, 2003, Pages 265-271

  Leunen, Karin ^a   Amant, Frederic ^a   Debiec Rychter, Maria ^b   Croes, Romaric ^a   Hagemeijer, Anne ^b   Schoenmakers, Eric F P M ^c   Vergote, Ignace ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chemotherapy; Cytogenetic; Endometrial stromal sarcoma; Pregnancy; Symptom

Indexed keywords

DOXORUBICIN; IFOSFAMIDE;

ADULT; ARTICLE; CANCER CYTODIAGNOSIS; CANCER INVASION; CARCINOGENESIS; CASE REPORT; CHEMOSENSITIVITY; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; ENDOMETRIUM BIOPSY; ENDOMETRIUM SARCOMA; ENDOMETRIUM STROMAL SARCOMA; FEMALE; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LAPAROTOMY; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL;

EID: 0141645565     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(03)00477-3     Document Type: Article

References (28)

1. Nordal R.R., Thoresen S. Uterine sarcomas in Norway 1956-1992 Incidence, survival and mortality . Eur J Cancer. 33:1997;907-911.
2. Bodner K., Bodner-Adler B., Obermair A., Windbichler G., Petru E., Mayerhofer S., Czerwenka K., Leodolter S., Kainz C., Mayerhofer K. Prognostic parameters in endometrial stromal sarcoma a clinicopathologic study in 31 patients . Gynecol Oncol. 81:2001;160-165.
3. Chang K.L., Crabtree G.S., Lim-Tan S.K., Kempson R.L., Hendrickson M.R. Primary uterine endometrial stromal neoplasms a clinicopathologic study of 117 cases . Am J Surg Pathol. 14:1990;415-438.
4. Oliva E., Clement P.B., Young R.H. Endometrial stromal tumors An update on a group of tumors with a protean phenotype . Adv Anat Pathol. 7:2000;257-281.
5. Zaloudek C., Hendrickson M.R. Mesenchymal tumors of the uterus. Kurman R.J. Blaustein's pathology of the female genital tract. 5th ed:2002;583-593 Springer-Verlag, New York.
6. Norris H.J., Taylor H.B. Mesenchymal tumors of the uterus. A clinical and pathological study of 53 endometrial stromal tumors. Cancer. 19:1996;755-766.
7. Berchuck A.B., Rubin S.C., Hoskins W.J., Saigo P.E., Pierce V.K., Lewis J.L. Treatment of endometrial stromal tumors. Gynecol Oncol. 36:1990;60-65.
8. Koontz J.I., Lee Soreng A., Nucci M., Kuo F.C., Pauwels P., Van den Berghe H., Dal Cin P., Fletcher A., Sklar J. Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci USA. 98:2001;6348-6353.
9. Silverberg S.G. Low-grade endometrial stromal sarcoma A rare but often puzzling diagnostic problem . Pathol Case Reviews. 5:2000;173-180.
10. Tavassoli, A clinicopathological study of 60 endometrial stromal nodules. Histopathology 1981;5:1-10.
11. Vergote I., Kaern J., Abeler V., Pettersen E., De Vos L., Tropé C. Analysis of prognostic factors in stage I epithelial ovarian carcinoma importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapse . Am J Obstet Gynecol. 169:1993;40-52.
12. Guidelines for Cancer Cytogenetics, Supplement of An International System For Human Cytogenetic Nomenclature. 1995;S. Karger, Basel.
13. Chu P., Arber D.A. Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Am J Clin Path. 113:2000;374-382.
14. Mc Cluggage W.G., Sumathi V.P., Maxwell P. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasm's. Histopathology. 39:2001;273-278.
15. Toki T., Shimizu M., Takagi Y., Ashida T., Konishi I. CD10 is a marker for normal and neoplastic endometrial stromal cells. Int J Gynecol Pathol. 21:2002;41-47.
16. Curtin J.P., Kavangh J.J., Fox H., Spanos W.J. Corpus mesenchymal tumors . Hoskins W.J., Perez C.A., Young R.C. Principles and practice of gynecologic oncology. 3rd ed. 2000;961-979 Lippincott Williams & Wilkins, Philadelphia.
17. Katsanis W.A., O'Conner D.M., Gibb R.K., Bendon R.W. Endometrial stromal sarcoma involving the placenta. Ann Diagn Pathol. 2:1998;301-305.
18. Mansi J.L., Ramachandra S., Wiltshaw E., Fisher C. Case report Endometrial stromal sarcomas . Gynecol Oncol. 36:1990;113-118.
19. Amant F, Moerman Ph, Cadron I, Neven P, Berteloot P, Vergote I. The diagnostic problem of endometrial stromal sarcoma: report of six cases. Gynecol Oncol, in press.
20. Styron S.L., Burke T.W., Linville W.K. Case report. Low-grade endometrial stromal sarcoma recurring over three decades. Gynecol Oncol. 35:1989;275-278.
21. Maluf F.C., Sabbatini P., Schwartz L., Xia J., Aghajanian C. Case report. Endometrial stromal sarcoma objective response to Letrozole . Gynecol Oncol. 82:2001;384-388.
22. O'Brein A.A., O'Briain S., Daly P.A. Aggressive endometrial stromal sarcoma responding to medroxyprogesterone following failure of tamoxifen and combination chemotherapy. Case report. Br J Obstet Gynecol. 92:1995;862-866.
23. Piura B., Rabinovich A., Yanai-Inbar I., Cohen Y., Glezerman M. Uterine sarcoma in the south of Israel study of 36 cases . J Surg Oncol. 64:1997;55-62.
24. Knocke T.H., Kucera H., Dörfler D., Pokrajac B., Pötter R. Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri. Cancer. 83:1998;1972-1979.
25. August C.Z., Bauer K.D., Lurain J., Murad T. Neoplasms of endometrial stroma Histopathologic and flow cytometric analysis with clinical correlation . Hum Pathol. 20:1989;232-237.
26. Hitchcock C., Norris H. Flow cytometric analysis of endometrial stromal sarcoma. Am J Clin Pathol. 97:1992;267-271.
27. Blom R., Malmstrom H., Guerrieri C. Endometrial stromal sarcoma of the uterus a clinicopathologic, DNA flow cytometric, p53 and mdm-2 analysis of 17 cases . Int J Gynecol Cancer. 9:1999;98-104.
28. Amant F., Moerman P.h, Cadron I., Hagemeijer A., Vergote I., Debiec-Rychter M. Endometrial stromal sarcoma with a sole t(X;17) chromosome change report of a case and review of the literature . Gynecol Oncol. 88:2003;459-462.